title: 99mTc sestamibi and 99mTc tetrofosmin scintigraphy for predicting resistance to chemotherapy: a critical review of clinical data.
authors.forename: C
authors.initials: C
authors.lastname: Van de Wiele
authors.forename: S
authors.initials: S
authors.lastname: Rottey
authors.forename: I
authors.initials: I
authors.lastname: Goethals
authors.forename: J
authors.initials: J
authors.lastname: Buscombe
authors.forename: S
authors.initials: S
authors.lastname: Van Belle
authors.forename: F
authors.initials: F
authors.lastname: De Vos
authors.forename: R A
authors.initials: RA
authors.lastname: Dierckx
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy; D002277:Carcinoma / Q000000981:diagnostic imaging / Q000188:drug therapy; D019008:Drug Resistance, Neoplasm; D004358:Drug Therapy / Q000379:methods; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D011379:Prognosis; D019275:Radiopharmaceuticals; D012509:Sarcoma / Q000000981:diagnostic imaging / Q000188:drug therapy; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D019275:Radiopharmaceuticals